Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.

CME information and select publications here

Community discussion

Join the conversation

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar

You May Also Like

Trent Loos Podcast

Real Ghost Stories Online

Breaking Down: Collapse

The Grave Talks | Haunted, Paranormal & Supernatural

The Best of Coast to Coast AM

Eye On The Sky

Мослекторий

UAP Files Podcast

Farm Small Farm Smart Daily

Daily Paper Cast